The Molecular Clamp technology

We are committed to developing highly innovative and effective vaccines to target life-threatening respiratory viral infectious diseases

About Vicebio

We were founded to develop the patented Molecular Clamp technology invented at The University of Queensland, Australia and exclusively licensed to Vicebio by UniQuest, the commercialisation company of UQ. The Molecular Clamp technology stabilises viral glycoproteins in “prefusion” conformation, to deliver highly protective and ready-to-use fully liquid vaccines.